Spots Global Cancer Trial Database for cavatak
Every month we try and update this database with for cavatak cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI) | NCT02307149 | Melanoma | CAVATAK Ipilimumab | 18 Years - | Viralytics | |
Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI) | NCT02307149 | Melanoma | CAVATAK Ipilimumab | 18 Years - | Viralytics | |
Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA) | NCT02565992 | Melanoma | CAVATAK Pembrolizumab | 18 Years - | Viralytics | |
A Study of the Intratumoural Administration of CAVATAK to Head and Neck Cancer Patients (VLA-X06) | NCT00832559 | Head and Neck C... | CVA21 | 18 Years - | Viralytics | |
CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON) | NCT02316171 | Non-muscle Inva... | CVA21 Mitomycin C | 18 Years - | Viralytics |